Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomasz Krzysztofiak
Observed name:
T. Krzysztofiak
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Azienda Ospedaliera S.Maria,
The Maria Sklodowska-Curie National Research Institute of Oncology,
University of Bologna
ORCID:
0000-0002-6003-0709
Observed ORCID:
0000-0002-6003-0709
OpenAlex ID:
A5012205941
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients
2023
·
Marcin Miszczyk
, Łukasz Magrowski
, et al.
·
Radiotherapy and Oncology
·
26
PDF
Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy
2019
·
Sylwia Kellas-Ślęczka
, Brygida Białas
, et al.
·
Brachytherapy
·
22
High dose rate brachytherapy in nonmelanoma skin cancer—Systematic review
2022
·
Tomasz Krzysztofiak
, Grażyna Kamińska‐Winciorek
, et al.
·
Dermatologic Therapy
·
14
PDF
Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer’s Response
2023
·
Tomasz Krzysztofiak
, Magdalena Suchorzepka
, et al.
·
Dermatology and Therapy
·
11
PDF
Basal Cell Carcinoma Treated with High Dose Rate (HDR) Brachytherapy—Early Evaluation of Clinical and Dermoscopic Patterns during Irradiation
2021
·
Tomasz Krzysztofiak
, Grażyna Kamińska-Winciorek
, et al.
·
Cancers
·
10
PDF
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy
2022
·
Łukasz Magrowski
, Oliwia Masri
, et al.
·
Biomedicines
·
9
PDF
Advanced dose calculation algorithm in superficial brachytherapy – the impact of tissue inhomogeneity on treatment plan dosimetry
2021
·
Marta Szlag
, Sylwia Kellas-Ślęczka
, et al.
·
Journal of Contemporary Brachytherapy
·
8
PDF
Individual multi-catheter mould technique in high-dose-rate brachytherapy – personalized approach in treating multifocal angiosarcoma of the face
2019
·
Marta Szlag
, Piotr Wojcieszek
, et al.
·
Journal of Contemporary Brachytherapy
·
7
PDF
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
2024
·
Matthias Moll
, Łukasz Magrowski
, et al.
·
Strahlentherapie und Onkologie
·
4
Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis
2023
·
Marcin Miszczyk
, Agata Suleja
, et al.
·
Radiotherapy and Oncology
·
4
PDF
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
2022
·
Marcin Miszczyk
, Łukasz Magrowski
, et al.
·
Journal of Contemporary Brachytherapy
·
4
PDF
Polish Brachytherapy Society clinical recommendations and expert consensus on radical high-dose-rate brachytherapy for prostate cancer
2026
·
Artur J. Chyrek
, Marcin Hetnał
, et al.
·
Journal of Contemporary Brachytherapy
·
3
PDF
Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results
2022
·
Sylwia Kellas-Ślęczka
, Piotr Wojcieszek
, et al.
·
Journal of Contemporary Brachytherapy
·
3
PDF
Grade migration and important prognostic factors in a pathology specimen for radical radiotherapy in prostate cancer patients
2022
·
Wojciech Majewski
, Dariusz Lange
, et al.
·
Polish Journal of Pathology
·
2
PDF
Skin Cosmesis assessment tools and methods in patients with non-melanoma skin cancers treated with radiotherapy: Systematic review on behalf of the ESTRO skin and soft tissue focus group and the GEC-ESTRO head and neck and skin working group
2026
·
Romaana Mir
, Marcin Miszczyk
, et al.
·
Clinical and Translational Radiation Oncology
·
1
PDF
Does Brachytherapy Boost Improve Biochemical Control in Intermediate and High-Risk Prostate Cancer Patients Compared to External Beam Radiotherapy Alone?
2021
·
M. Miszczyk
, I. Jabłońska
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
OC-0319 Twelve-year clinical outcomes with APBI with interstitial multicathether brachytherapy after BCS
2019
·
S. Kellas-Sleczka
, B. Bialas
, et al.
·
Radiotherapy and Oncology
·
1
PDF
3479 Skin Cosmesis Assessment Tools for Patients with Keratinocyte Carcinoma: A Systematic Review on Behalf of the ESTRO Skin and Soft Tissue Focus Group
2026
·
Romaana Mir
, Marcin Miszczyk
, et al.
·
Radiotherapy and Oncology
Basal cell carcinoma after HDR brachytherapy, changes in clinical and dermoscopic patterns in long term observation
2026
·
G. Kaminska-Winciorek
, T. Krzysztofiak
, et al.
·
EJC Skin Cancer
PDF
Skin Cosmesis Assessment Tools for Patients with Keratinocyte Carcinoma:A Systematic Review on Behalf of the ESTRO Skin and Soft Tissue FocusGroup
2026
·
R. Mir
, M. Miszczyk
, et al.
·
EJC Skin Cancer
PDF
MSS08 Presentation Time: 4:20 PM
2022
·
Tomasz Krzysztofiak
, Grażyna Kamińska-Winciorek
, et al.
·
Brachytherapy
The Association between Dose Escalation and Risk of Developing Metastases in Intermediate and High-Risk Prostate Cancer Patients Treated with Radiotherapy
2022
·
M. Miszczyk
, Ł. Magrowski
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PO-1358 Does brachytherapy boost improve biochemical control in intermediate and high-risk prostate cancer?
2021
·
M. Miszczyk
, I. Jabłońska
, et al.
·
Radiotherapy and Oncology
PO-1336 Salvage HDR brachytherapy for localised recurrent prostate cancer after primary irradiation
2021
·
M. Stankiewicz
, P. Wojcieszek
, et al.
·
Radiotherapy and Oncology
PO-1368 What is clinically important in the pathology specimen for radical radiotherapy in prostate cancer?
2021
·
W. Majewski
, D. Lange
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
37
Citation count:
130
H-index:
7
I10-index:
5
Year
Topic
Type